Try our Advanced Search for more refined results
Life Sciences - April, 2011
213 articles
- Actelion Must Pay Asahi $550M In Fasudil Suit: Jury
- Ex-MedQuist CFO Settles SEC Suit Over Billing Fraud
- Accused Trader Seeks To Subpoena Lehman, Barclays
- Baxter IP Counsel Tapped For Chief Patent Judge Post
- How The FDA Can Compel Post-Marketing Studies
- Lilly, SEC Push Toward Deal In FCPA Probe
- Reed Smith Lures Tech Deals Pro From Gibson Dunn
- Getting Out Of The Eastern District Of Texas
- Expertly Navigating Federal Expert Disclosure Rules
- Celgene Sues Americord Over Stem Cell Marketing
- Shire Sues Sandoz Over Planned Generic Intuniv
- Allergan Hit With $212M Verdict In Botox Suit
- Researcher Renews CVS Fight Over Prescription Data
- EU Probes Cephalon, Teva Deal Over Generic Provigil
- FDA Must Act Quickly On Ranbaxy Lipitor ANDA: Mylan
- Merck To Abide By Discharge Diet To End Enviro Suit
- Davis Polk Reps Aetna In $600M Prodigy Health Buy
- Using Injunctions In 'Bet-The-Company' Litigation
- Weighing Generic Litigation In The ITC
- Par Pharmaceutical Settles Medicaid Suits For $154M
- Lilly Wins Order Banning Generic Cymbalta Sales
- Abbott Appeals $3.5M OT Ruling In 7th Circ.
- Genzyme Sues Over Endo's Bid To Sell Generic Renvela
- Asahi, Actelion Throw Final Punches In Fasudil IP Row
- Mayo Wins Trade Secrets Verdict Against Ex-Employee
- Duane Reade Settles Medicaid Fraud Suit
- Albemarle Hit With CWA Suit Over Pharma Production
- FOIA Request Filed As Avastin Safety Hearing Nears
- Patent Reform Lobbying Pays Big For Akin Gump
- Hospira, Others Sued Over Infusion Pump Patent
- FTC Orders Hikma To Shed Drugs For $112M Baxter Deal
- Cravath, Weil Rep J&J In $21B Deal To Buy Synthes
- BP, AstraZeneca Settle Suit Over Seed IP Sale
- High Court Mulls Vt. Limits On Use Of Drug Data
- Judge Zaps Palomar's Laser Hair Removal IP Claims
- Elan Targets Teva Again Over Generic Focalin XR
- $251M Animal Health Co. Merger Moves Forward
- Metro Med Workers Sentenced For $23M Medicare Fraud
- FedEx, Delta Sued Over Web Communication IP
- Genzyme Asks To Add New Patent To Arthritis Drug Suit
- Pharmacist Hits Omnicare With Meal Break Class Action
- FDA To Repackage E-Cigarettes As Tobacco Products
- Baxter, CSL Look To Nix County's Blood Plasma Suit
- WHPM Hit With $20M Suit Over Drug Test Kits
- Non-Spock Economics In Antitrust
- Mutual Sues West-Ward Over Gout Drug Patents
- AstraZeneca, Pozen Sue Dr. Reddy's Over Vimovo Patent
- St. Jude Wins $2.3B Verdict In Trade Secrets Trial
- Northgate Infringes Lexion Laparoscopy IP: Fed. Circ.
- Yaz, Similar Pills Tied To Higher Blood Clot Risks
- Plaintiffs Fear Retaliation In MiraLax Antitrust Suit
- Genentech Sues Sandoz Over Generic Valcyte
- Judge Nixes New Trial For Braun, Terumo Catheter Row
- Ranbaxy Can't Dodge Lupin's Suit Over Generic Antara
- Fund Wants J&J To Pay Up For Faulty Hip Implants
- Cardinal Health Settles Kickback Claims For $8M
- FDA Cautions Lifetech Over Eyelash Growth Products
- Ciba Ends Combative Ads To Settle Bausch & Lomb Case
- New Equity Committee Sinks Point Blank Ch. 11 Plan
- Feds Seek Deal Time In $3M FDA Chemist Trading Case
- Sanofi Free To Appeal Genentech Patent Ruling
- GSK, Scottrade Settle IP Suits Over Navy Technology
- Shire Sues Mylan Over Intuniv Patents
- Wyeth, Dr. Reddy's Strike Deal Over Effexor Patents
- Certifying To Medical Necessity Under FDA
- Webvention Targets Merck, Others In Web Data IP Suit
- Feds Want GSK VP To Testify In Wellbutrin Case
- Aetna Loses Bid To Re-Enter Pfizer Off-Label MDL
- Bayer Sues Mylan Over Generic Yaz
- MetaMorphix Scores Ch. 7 Conversion
- Novartis Targets Teva Over Myfortic Patents
- No New Trial For Former InterMune CEO
- US Cracks Down On Prescription Drug Abuse
- Judge Tosses Most Claims In Medtronic Class Action
- Off-Label Use Of Novo Drug May Harm Patients: Study
- AstraZeneca Sued Over Nexium Bone Fracture Risks
- Texas Hospital Fights To Sink Medicare Fraud Suit
- 2nd Circ. Nixes Suit Over University's Medicare Bills
- Genzyme, Daiichi Sue Watson Over Generic Welchol
- Raising The Bar On Proving Damages
- Defense Absent As St. Jude Trade Secrets Trial Begins
- Caraco Investors Seek Class Cert. In Stock Price Suit
- Suits Force Celera's Hand On $344M Merger With Quest
- Allergan Targets Sandoz Over Generic Latisse
- McCarter Adds Patent Attorney From Foley & Lardner
- Synthes Confirms Potential $20B Acquisition By J&J
- AstraZeneca, P&G Dodge Prilosec OTC Antitrust Suit
- 'Love And Other Drugs' In Real Life
- Harmonizing FDA Foreign And Domestic Inspections
- Welcome To The New Law360
- Merck, J&J Strike Deal In Arthritis Drugs Dispute
- FDA Ducks ViroPharma Suit Over Generics Guidelines
- Biotech Co., Mintz Levin Settle Suit Over Patents
- CVS Pays $17.5M To End False Claims Act Suit
- UK To Ban Lethal Injection Drug Exports To US
- Cypress Sued Over Unapproved Cold Medication
- FDA Issues Safety Warning On Teva's Generic Prevacid
- FTC Must Break Up CVS Caremark: Consumer Groups
- Judge Blocks Par Pharma's Generic Treximet
- Wyeth, Orchid Reach Deal In Effexor Patent Fight
- UK Court Strikes Down Infosint Patent In Citalopram Suit
- UHS Demands More Info From Rival In Antitrust Suit
- Ex-InterMune CEO Gets House Arrest For Drug Claims
- Ex-GSK Lawyer Faces New Obstruction Indictment
- Genzyme Sues Seikagaku Over Synvisc-One Patent
- FDA Recalls Radiation Shield That Sheds Tungsten
- Axcan To Pay Up To $230M For Rival Mpex
- 1st Circ. Won't Rehear Puerto Rico Bank's Merger Suit
- Penumbra Pulls Aneurysm Device Over Deadly Defects
- Align Buy Of Dental Scan Co. Isn't Crooked, FTC Says
- JPML To Weigh Consolidation Of Darvocet Cases
- Arguments On Appeal: FTC V. Lundbeck
- Takeda Drops Suit Over Apotex's Actos ANDA
- Applying American Pipe In State Courts
- J&J Recalls 57K Bottles Of Topamax Over Odor
- HGS Fires Round 2 At Genentech Over Lupus Drug IP
- Bill Seeks To Temper FDA Oversight Of Drug Imports
- FDA Warns Philips Over Fatal Defibrillator Defects
- Zyprexa Payors Ask High Court For Shot At Eli Lilly
- FDA Must Improve Medical Device Oversight, GAO Says
- Vioxx MDL Attys Want 3 Firms Backing Fee Plan KO'd
- FDA Urged To Help Get Prandin Row To High Court
- Calif. Wades Into Sutter Health Insurance Fraud Suit
- Lawyers Trade Blows Over Asahi, Actelion Trial Conduct
- Braun Can't Dodge False Marking Claims On IV Fluids
- Judge Says Cordis Stent Infringes BSC Patent
- Quest's $344M Celera Buy Averts Antitrust Hurdle
- Feds Charge FrontPoint Trader In $30M Inside Tips Case
- Moog Infusion Pumps Face Class I Recall
- Schneider Seeks To Quash Rumors Of $30B Tyco Offer
- Bryan Cave Reps Silgan In $4B Graham Packaging Deal
- More Big-Money Bias Suits Coming, Plaintiffs Firm Says
- Inspire Investor Challenges $430M Merck Deal
- Parties Offer Bellwether Plan In NuvaRing MDL
- Ropes & Gray Nabs IP Litigator From Sidley
- Fresenius Dialysis Device Faces FDA Scrutiny
- Chem Rx Liquidation Plan Wins OK After Amendments
- Hologic Sues IZI Over Mammogram Cushion Patent
- Dewey Lures Tech Deals Pro From Fulbright
- Sidley Reps SXC In UMass Benefits Manager Pickup
- Purdue Sues Impax, Ranbaxy Over Generic OxyContin
- Revlimid Cancer Woes Spark FDA Safety Review
- Former US Rep. Stupak Joins Venable Policy Group
- Merck, Sun Pharma Form Generics Joint Venture
- Skadden Reps Endo In $2.9B American Medical Buy
- Judge Says No To Generic Amrix
- Nautilus Sues Wockhardt Over Cambia ANDA
- Abbott To Pay $52M To Norvir Direct Purchaser Class
- Pfizer Wins Approval Of Unit's $265M Asbestos Deal
- UK Court Shutters Merck's Cosopt Patent Fight
- Microsoft Sues DataTern Over Database Patents
- Obama Taps Former Trade Attorney For ITC Post
- Ex-Point Blank CEO Fights Deregistration Plan
- GSK Rival Barred From Infringing Aquafresh Mark
- False Marking Cases On Shaky Ground After BP Ruling
- No Sympathy For Off-Label Scripts Suits
- J&J Pays $78M To Settle Foreign Bribery Cases
- Judge Nixes Releases In Chem Rx Ch. 11 Plan
- FDA Blasts Mylan Suit Over Generic Lipitor Exclusivity
- 4-Partner Litigation Team Joins Gibson Dunn In NY
- Minsurg Infringement Claims Survive Dismissal Bid
- Alcon Sues Watson Over Vigamox Patents
- Shareholder Suits Over Genoptix Sale Consolidated
- Blinded Mexican Patients Can Bring US Suit: 9th Circ.
- Angiotech Wins US Approval Of Canada Restructuring
- Kaye Scholer Reps Novartis In $420M Elidel Sale
- Deformed Consent
- Judge Tosses Challenge To FDA Supplement Rules
- FDA Orders Seizure Of $6M In Products At Triad Plant
- Latham & Watkins Nets Wilson Sonsini IP Group
- Jury To Weigh Lost Profits In Neurontin Patent Fight
- Shire Sues Watson Again Over Adderall Patents
- Is It Material? Depends On Who You Ask
- Ex-Sonsini Atty Charged In $32M Insider Trading Case
- The FTC And State Health Care Regulation
- Cephalon Board Rejects Valeant's $5.7B Merger Bid
- Pfizer Securities Fraud Suit Must Stay In NJ: Judge
- Ortho Can't Shake False Marking Claims On 5 Drugs
- Galderma, Dermalogix End Clobex Suit Against Paddock
- 166 Plaintiffs Tossed From Neurontin MDL
- Fed. Circ. Mulls Smith & Nephew $5.2M Patent Win
- FTC Clears Cephalon's $225M Gemin X Buyout
- Palmetto Targets AstraZeneca's Crestor In IP Suit
- Hill-Rom Targets Stryker Over Bed, Stretcher Patents
- Comcast, Pepsi, Others Hit With Database Patent Suit
- Fried Frank Reps Merck In $430M Inspire Deal
- 7 Ways To Avoid Privacy And Data Security Trouble
- Eaton Sales Reps Seek $150M In Sex Bias Suit
- Lilly Sues Generics Maker Over Zyprexa Patent
- Lupin Unit Sues Ranbaxy Again Over Generic Antara
- Conceptus Fired Salesman For Overbilling Report: Suit
- Amgen Expert Report Allowed In Aranesp Kickback Suit
- Myriad Pushes For Isolated DNA Patents In Fed. Circ.
- Cubist, Teva Settle IP Suit Over Generic Cubicin
- NC Hospital To Pay $1.9M To End Medicare Fraud Suit
- Abbott, Elan Drop Tricor IP Suits Against Biovail
- Takeda Targets Dr. Reddy's Over Generic Dexilant
- Solvay Spreads Global Reach With $4.8B Rhodia Buy
- A Winning Strategy For Beating IPO Class Actions
- Taming Of The 'Ostrich Officers'
- Simpson Reps KKR In $2.4B Pfizer Capsule Unit Buy
- ReGen Using Menaflex IP After Rights Transfer: Suit
- BSC Poached Worker Suit To Move Forward In Calif.
- Fed. Circ. Restores Validity Of Can Construction IP
- Eurand, Anesta Sue Anchen Over Generic Amrix
- DOJ Sues Healthpoint Over Zenaderm Marketing
- Kwikset Ruling To Reignite False Ad Suits By Rivals
- Stryker Claims Zimmer Stole Employees
- Mintz Levin Lures Ober Kaler Health Antitrust Guru
- Allergan Sues Lupin Over Zymaxid Patents
- Drug Test Co. Lured Doctors With Kickbacks, Rival Says
- HIF, BizBiotech Must Face IP Claims In Federal Court
- Judge Denies Injunction In Animal Imaging IP Spat